Real-time enrollment status for this melanoma clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT05352672 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Melanoma |
| Phase | Clinical Trial |
| Target Enrollment | 1,535 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | December 22, 2025 (Dec 22, 2025) |
As of March 2, 2026: Clinical trial NCT05352672 is currently active_not_recruiting participants. This clinical trial study for melanoma is not currently accepting new participants at 8 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05352672 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05352672 was last updated Dec 22, 2025 (December 22, 2025). HelloStudys verifies this status automatically.